MedPath

Efficacy of the ATLAS Medical Device on Pain in Patients With Low Back Pain Due to Lumbar Disc Disease

Not Applicable
Terminated
Conditions
Lumbar Disc Disease
Interventions
Other: Visual analog scale
Other: Mac Gill Pain Questionnaire
Other: Roland and Morris Disability Questionnaire
Other: Quebec questionnaire
Registration Number
NCT04585386
Lead Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Brief Summary

Monocentric, comparative, randomized, controlled interventionnal study in 2 parallel groups, aiming to compare the efficacy of the ATLAS device with that of a standard lumbar belt on the reduction of pain felt in patients with subacute or chronic low back pain with lumbar disc disease.

Detailed Description

The main expected benefit is a reduction in pain experienced in patients with subacute or chronic low back pain during and after wear. Consequently, an improvement in the quality of daily life is expected with a less significant impact of low back pain.

The main objective of the study is to compare the efficacy of the ATLAS medical device with a standard lumbar support belt in terms of immediate reduction of low back pain experienced in patients with subacute or chronic low back pain.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Patient suffering from subacute (for 6 to 12 weeks) or chronic (> 3 months) lumbar pain;
  • Lumbar disc disease confirmed by Magnetic Resonance Imaging (MRI) less than 3 months old;
  • Patient with lumbar pain ≥ 40mm on the visual analogue scale (VAS) at inclusion;
  • Patient in whom a lumbar belt / restraint is considered for a short period to help resumption of activity;
  • Patient with internet and a camera (by phone or computer) and agreeing to use them as part of the study's teleconsultations;
  • Patient capable of understanding the information related to the study (absence of linguistic, psychological, cognitive problem, etc.), of reading the information leaflet, of completing questionnaires and agreeing to sign the consent form.
Exclusion Criteria
  • Patient with neurological radicular or medullary deficits;
  • Patient presenting a postural problem with lateralized contracture;
  • Skin pathology in the trunk region and / or contusions and injuries by stretching the trunk;
  • History of spinal arthrodesis surgery;
  • History of cauda equina syndrome;
  • Patient treated by implanted neurostimulation;
  • Scoliosis with Cobb angle> 30 °;
  • History of recent fracture of the dorsolumbar spine (<3 months);
  • History of recent rib fracture (<3 months);
  • History of recent herniated disc surgery (<3 months);
  • Patient with diagnosed fracture osteoporosis;
  • Patient with heart or circulatory disease or respiratory failure;
  • Patient presenting with a tumor or infectious process of the vertebrae;
  • Pregnant or likely to be (of childbearing age, without effective contraception) or breastfeeding;
  • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
  • Patient not beneficiary of a social security scheme.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard lumbar support beltVisual analog scaleStandard lumbar support belt : LombaSkin® or Lombogib®
ATLASMac Gill Pain QuestionnaireMedical device named ATLAS which is an "active corset" (rigid lumbar restraint) and connected.
ATLASVisual analog scaleMedical device named ATLAS which is an "active corset" (rigid lumbar restraint) and connected.
Standard lumbar support beltRoland and Morris Disability QuestionnaireStandard lumbar support belt : LombaSkin® or Lombogib®
Standard lumbar support beltQuebec questionnaireStandard lumbar support belt : LombaSkin® or Lombogib®
ATLASRoland and Morris Disability QuestionnaireMedical device named ATLAS which is an "active corset" (rigid lumbar restraint) and connected.
ATLASQuebec questionnaireMedical device named ATLAS which is an "active corset" (rigid lumbar restraint) and connected.
Standard lumbar support beltMac Gill Pain QuestionnaireStandard lumbar support belt : LombaSkin® or Lombogib®
Primary Outcome Measures
NameTimeMethod
Evolution of the lumbar pain1 hour after the start of the port

The primary outcome measure is the change in lumbar pain assessed by the patient using an VAS from 0 to 100 mm.

Secondary Outcome Measures
NameTimeMethod
To assess the safety and tolerance of the devicesBetween Day 0 and Day 8

Analysis of all adverse events collected during the study

Satisfaction of the patientAfter a period of 8 days of wearing the medical device

Percentage of patients with an overall assessment of the device

Trial Locations

Locations (1)

Hôpital Privé Le Bois

🇫🇷

Lille, France

Hôpital Privé Le Bois
🇫🇷Lille, France
© Copyright 2025. All Rights Reserved by MedPath